arginine has been researched along with dx 9065a in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kambayashi, J; Kawasaki, T; Kim, DI; Sakon, M; Shibuya, T | 1 |
| Prasa, D; Stürzebecher, J; Svendsen, L | 1 |
| Hara, T; Kunitada, S; Morishima, Y; Tanabe, K; Terada, Y | 1 |
| Nagashima, H | 2 |
| Fareed, J; Gerbutaviciene, R; Gerbutavicius, R; Griniute, R; Hoppensteadt, DA; Iqbal, O; Messmore, HL; Wehrmacher, WH | 1 |
| Ieko, M; Koike, T; Naito, S; Nakabayashi, T; Takeda, M; Tarumi, T | 1 |
7 other study(ies) available for arginine and dx 9065a
| Article | Year |
|---|---|
In vivo evaluation of DX-9065a, a synthetic factor Xa inhibitor, in experimental vein graft.
Topics: Animals; Anticoagulants; Antithrombins; Arginine; Blood Vessel Prosthesis; Disease Models, Animal; Factor Xa Inhibitors; Graft Occlusion, Vascular; Heparin; Male; Microscopy, Electron, Scanning; Naphthalenes; Pipecolic Acids; Propionates; Rabbits; Sulfonamides; Thrombosis | 1996 |
Inhibition of thrombin generation in plasma by inhibitors of factor Xa.
Topics: Animals; Anticoagulants; Arginine; Arthropod Proteins; Cattle; Dipeptides; Factor Xa; Factor Xa Inhibitors; Fibrinolytic Agents; Hirudins; Humans; Intercellular Signaling Peptides and Proteins; Kinetics; Molecular Structure; Naphthalenes; Partial Thromboplastin Time; Peptides; Pipecolic Acids; Piperidines; Propionates; Rabbits; Recombinant Proteins; Serine Proteinase Inhibitors; Sulfonamides; Sulfones; Thrombin; Thromboplastin | 1997 |
Antithrombotic and hemorrhagic effects of DX-9065a, a direct and selective factor Xa inhibitor: comparison with a direct thrombin inhibitor and antithrombin III-dependent anticoagulants.
Topics: Animals; Anticoagulants; Antithrombin III; Arginine; Bleeding Time; Blood Coagulation; Disease Models, Animal; Factor Xa Inhibitors; Hemorrhage; Heparin, Low-Molecular-Weight; Male; Naphthalenes; Peptide Hydrolases; Pipecolic Acids; Propionates; Rats; Rats, Wistar; Sulfonamides; Thrombin; Thrombosis | 1997 |
Studies on the different modes of action of the anticoagulant protease inhibitors DX-9065a and Argatroban. II. Effects on fibrinolysis.
Topics: Anticoagulants; Arginine; Blood Coagulation; Fibrinolysis; Humans; Kinetics; Naphthalenes; Pipecolic Acids; Propionates; Sulfonamides; Thrombomodulin; Thromboplastin | 2002 |
Studies on the different modes of action of the anticoagulant protease inhibitors DX-9065a and Argatroban. I. Effects on thrombin generation.
Topics: Anticoagulants; Arginine; Binding, Competitive; Blood Coagulation; Humans; Kinetics; Models, Theoretical; Naphthalenes; Pipecolic Acids; Platelet Aggregation Inhibitors; Propionates; Serine Proteinase Inhibitors; Sulfonamides; Thrombin | 2002 |
Differential effects of DX-9065a, argatroban, and synthetic pentasaccharide on tissue thromboplastin inhibition test and dilute Russell's viper venom test.
Topics: Anticoagulants; Arginine; Blood Coagulation; Dose-Response Relationship, Drug; Female; Humans; Kinetics; Male; Naphthalenes; Oligosaccharides; Partial Thromboplastin Time; Pipecolic Acids; Propionates; Prothrombin Time; Sulfonamides | 2003 |
Synthetic selective inhibitors of coagulation factor Xa strongly inhibit thrombin generation without affecting initial thrombin forming time necessary for platelet activation in hemostasis.
Topics: Anticoagulants; Arginine; Blood Platelets; Cells, Cultured; Enzyme Inhibitors; Factor Xa Inhibitors; Hemostasis; Humans; Naphthalenes; Partial Thromboplastin Time; Pipecolic Acids; Piperidines; Platelet Activation; Propionates; Prothrombin Time; Pyridines; Sulfonamides; Tetrahydroisoquinolines; Thrombin | 2004 |